Ocumension Therapeutics (HKG:1477)
Hong Kong · Delayed Price · Currency is HKD 7.09
+0.01 (0.14%)
May 7, 2026, 4:08 PM HKT
Ocumension Therapeutics Market Cap
Ocumension Therapeutics has a market cap or net worth of 5.78 billion as of May 7, 2026. Its market cap has increased by 51.92% in one year.
Market Cap
5.78B
Enterprise Value
5.54B
Revenue
895.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.09
Market Cap Chart
Since July 10, 2020, Ocumension Therapeutics's market cap has decreased from 21.28B to 5.78B, a decrease of -72.84%. That is a compound annual growth rate of -20.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 5.77B | -4.32% |
| Dec 31, 2025 | 6.03B | 64.39% |
| Dec 31, 2024 | 3.67B | -20.44% |
| Dec 29, 2023 | 4.61B | -30.21% |
| Dec 30, 2022 | 6.61B | -43.35% |
| Dec 31, 2021 | 11.67B | -26.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lepu Biopharma | 9.20B |
| Abbisko Cayman | 8.55B |
| Shanghai Bao Pharmaceuticals | 8.48B |
| CK Life Sciences Int'l., (Holdings) | 7.02B |
| Guangzhou Innogen Pharmaceutical Group | 6.48B |
| Laekna | 5.80B |
| Jacobio Pharmaceuticals Group | 5.37B |
| Beijing Luzhu Biotechnology | 4.58B |